Basket | Login | Register


LO-MAPT (coming soon)

Phase III trials

Study Information

Name of the study

Prevention of cognitive decline in older adults with low Dha/Epa index in red blood cells

Study sponsor

University Hospital, Toulouse 


Subjective memory complaints or family history of Alzheimer's disease


Phase III

Information about the drug that will be tested in the study

Name of drug

Dietary supplement: Omega-3 treatment

Where and when will the study be conducted?

European countries involved in the trial


Estimated start date of recruitment

April 2018

Information for your doctor identifier


Study contact information

Bruno Vellas -

Arnaud Lendrieuy -

Link to full text

An accessible easy read information on the LO-MAPT study will be available soon.



Last Updated: Friday 09 August 2019